Deal Summary

TScan Therapeutics

$52,500,000

Term Loan

Silicon Valley Bank

Deal Notes:

Refinancing of existing convertible debt with K2 Health Ventures. First tranche of $32.5MM for debt retirement; second tranche of $20.0MM available upon mutual agreement. Interest rate between 7% and 9.75%, with maturity on 9/1/2029.
N/A

Industry:

Biotechnology

Role:

Lender, Lead Arranger

Event:

Recapitalization

Recent Deal Announcements